Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis
- PMID: 17152010
- DOI: 10.1086/509821
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis
Abstract
Background: Pseudomonas aeruginosa (PA) strains with defective DNA mismatch repair genes generate numerous bacterial variants because of high mutation rates. In cystic fibrosis (CF), such mutator strains may lead to the rapid selection of survivors that are specifically adapted to the hostile environment of the inflamed CF lung.
Methods: Genotypes and phenotypes of 111 PA variants descending from 3 distinct mutator strains obtained from 3 patients with CF were systematically characterized.
Results: We demonstrated that PA mutS isolates accumulated in the CF lung during the observation period of 3-6 years, with dominance during the final stage of the disease. Mutator strains from the final stage of disease were multiresistant and had lost a set of established virulence-associated traits, including cytotoxicity for bronchial epithelial cells (Calu-3) and macrophages (J774). This pathoadaptation was associated with the loss of survival capacity in a typical environmental habitat, such as tap water. Strikingly, nonmutator strains that maintained their virulence potential persisted as a minority, probably with a preference for the lower airways.
Conclusions: Mutator strains may evolve from the initially infecting PA strain and generate numerous variants with a loss of destructive virulence factors, probably because of selection for improved survival in the deteriorated CF lung but at the expense of the ability to live freely.
Similar articles
-
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.J Infect Dis. 2009 Jul 1;200(1):118-30. doi: 10.1086/599360. J Infect Dis. 2009. PMID: 19459782
-
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.Antimicrob Agents Chemother. 2005 Jun;49(6):2276-82. doi: 10.1128/AAC.49.6.2276-2282.2005. Antimicrob Agents Chemother. 2005. PMID: 15917521 Free PMC article.
-
Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x. Respirology. 2008. PMID: 18811887
-
Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.Behring Inst Mitt. 1997 Feb;(98):249-55. Behring Inst Mitt. 1997. PMID: 9382747 Review.
-
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.Int J Med Microbiol. 2010 Dec;300(8):557-62. doi: 10.1016/j.ijmm.2010.08.008. Epub 2010 Oct 12. Int J Med Microbiol. 2010. PMID: 20943439 Review.
Cited by
-
Phenotypes of a Pseudomonas aeruginosa hypermutator lineage that emerged during prolonged mechanical ventilation in a patient without cystic fibrosis.mSystems. 2024 Jan 23;9(1):e0048423. doi: 10.1128/msystems.00484-23. Epub 2023 Dec 22. mSystems. 2024. PMID: 38132670 Free PMC article.
-
Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.J Bacteriol. 2007 May;189(9):3665-8. doi: 10.1128/JB.00120-07. Epub 2007 Feb 16. J Bacteriol. 2007. PMID: 17307847 Free PMC article.
-
A population-level strain genotyping method to study pathogen strain dynamics in human infections.JCI Insight. 2021 Dec 22;6(24):e152472. doi: 10.1172/jci.insight.152472. JCI Insight. 2021. PMID: 34935640 Free PMC article.
-
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.BMC Genomics. 2015 Oct 30;16:883. doi: 10.1186/s12864-015-2069-0. BMC Genomics. 2015. PMID: 26519161 Free PMC article.
-
Breaking the rules: bacteria that use several DNA polymerase IIIs.EMBO Rep. 2011 May;12(5):408-14. doi: 10.1038/embor.2011.51. Epub 2011 Apr 8. EMBO Rep. 2011. PMID: 21475246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous